Success Stories: EB1-A Approval for a Pharmaceutical Sciences Research Scientist in 18 days
Client’s testimonial:
Thank you very much for your prompt and excellent support with my petition.
On May 28th, 2013, we received another EB1A Approval for a Research Scientist in the Field of Pharmaceutical Sciences (Approval Notice)
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Research Scientist
National Origin: India
Service Center: Nebraska Service Center (NSC)
State Residing at the Time of Filing: California
Approval Notice Date: May 28, 2013
Processing Time: 18 days (after the request for Premium Processing)
Case Summary:
Chen Immigration Law Associates recently received an EB1A approval for a research scientist in the field of pharmaceutical sciences. This client sought to enter the United States to continue his research focused on drug formulation and delivery, with particular emphasis on micro and nanoparticulate systems for small and large therapeutic molecules. It was our goal to prove that this client qualifies for classification as an alien of extraordinary ability given that he seeks to enter the United States to continue work in the area of extraordinary ability and that his entry into the United States will substantially and prospectively benefit the United States. Our client’s contributions to the field are also recognized by other experts in his field, notably in a statement by an independent recommender who stated, “He is at the to of his field and without his work, much of my own and that of our colleagues would be a lot weaker scientifically.” Furthermore, our client’s work has resulted in at least six peer-reviewed scientific articles, three book chapters, and eleven conference posters. His publications have been cited at least 106 times by researchers around the world. We at Chen Immigration Law Associates collected recommendation letters from leading experts in the field that argue the necessity of continuation of our client’s research. This client’s case was approved in only eighteen days after the request for Premium Processing.